Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival
Kerstin Wimmer(Comprehensive Cancer Center Vienna), Florian Fitzal, Guenther G. Steger(Mount Vernon Hospital), Farid Moinfar(AGO Austria), Michael Bolliger(Vienna General Hospital), Daniela Kauer-Dorner(Comprehensive Cancer Center Vienna), C. Gruber, Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Martina Mittlböck(Medical University of Vienna), Ruth Helfgott
Cited by 44
Related Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
|Journal of Clinical Oncology|2010|887
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
|Annals of Oncology|2021|799